Osteopontin Expression in Prostate Cancer and Benign Prostatic Hyperplasia

Publisher： Karger

E-ISSN： 1423-0399|62|3|155-158

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.62, Iss.3, 1999-10, pp. : 155-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxidative Stress in Benign Prostatic Hyperplasia and Prostate Cancer

By  

Urologia Internationalis, Vol. 85, Iss. 3, 2010-05 ,pp. : 328-333

Karger

Access to resources Recommend Favorite

Cytokeratin 8/18 Levels in Patients with Prostate Cancer and Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 60, Iss. 3, 1998-06 ,pp. : 152-155

Karger

Access to resources Recommend Favorite

Presence of PSA auto‐antibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis)

By  

ANDROLOGIA (ELECTRONIC), Vol. 47, Iss. 3, 2015-04 ,pp. : 328-332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of IL‐17A, E, and F and their receptors in human prostatic cancer: Comparison with benign prostatic hyperplasia

By  

THE PROSTATE, Vol. 75, Iss. 16, 2015-12 ,pp. : 1844-1856

John Wiley & Sons Inc

Access to resources Recommend Favorite

Significance of Vitamin D Receptor Gene Polymorphism for Risk and Disease Severity of Prostate Cancer and Benign Prostatic Hyperplasia in Japanese

By  

Urologia Internationalis, Vol. 68, Iss. 4, 2002-05 ,pp. : 226-231

Karger

Access to resources Recommend Favorite